Injectable Corticosteroids in Modern Practice

  title={Injectable Corticosteroids in Modern Practice},
  author={Brian J. Cole and Ralph H. Schumacher},
  journal={Journal of the American Academy of Orthopaedic Surgeons},
  • B. ColeR. Schumacher
  • Published 1 January 2005
  • Medicine
  • Journal of the American Academy of Orthopaedic Surgeons
Abstract Long‐lasting, crystalline suspensions of injectable corticosteroids have been used to treat joint and soft‐tissue disorders for many years; they decrease inflammation by reducing local infiltration of inflammatory cells and mediators. Depot formulations differ in their characteristics. Compounds with low solubility are thought to have the longest duration of action but may cause tissue atrophy when used in soft tissues. Intra‐articular corticosteroids are commonly used to treat… 

Figures and Tables from this paper

Injectable Corticosteroids: Take Precautions and Use Caution.

Evidence supports the use of injectable corticosteroids in the treatment of inflammatory tenosynovitis and bursitis associated with rheumatic diseases, trigger finger and de Quervain disease, and carpal tunnel syndrome, and the role of cortICosteroid injections in the management of rotator cuff disease remains unclear.

Injectable Medications for Osteoarthritis

Looking Back: Safety of Current Treatments

An overview of several common injectable agents for the treatment of musculoskeletal injuries and pathologies is provided, with a special focus on the safety profile of corticosteroids, viscosupplementation, and local anesthesic agents.

Intraarticular Corticosteroids for Hip Osteoarthritis: A Review

It is shown that intraarticular corticosteroid injections are efficacious in hip osteoarthritis and that this benefit can last up to 12 weeks, while the main characteristics and features of glucocorticoids are explained.

Intra-articular Corticosteroid Injections for Symptomatic Knee Osteoarthritis: What the Orthopaedic Provider Needs to Know.

The latest American Academy of Orthopaedic Surgeons clinical practice guideline does not support conclusive recommendations about the use of intra-articular corticosteroid injections for symptomatic knee osteoarthritis, but providers should be aware of the adverse effects and potential complications when using them in clinical practice.

Intra-articular glucocorticoid injection site: best practice guidelines

At the present stage, the role of local administration of glucocorticoids will increase as an effective way to reduce the activity of arthritis in any nosologically form, and the registration in the Russian Federation of a new form of betamethasone in pre-filled syringes makes it even more possible to avoid infectious complications.

The systemic immunosuppressive effects of peripheral corticosteroid injections: A narrative review of the evidence in the context of COVID‐19

The implications of the current evidence in relation to shared decision making, informed consent, risk management and COVID‐19 vaccination are discussed to provide clinicians with a pragmatic guide to help navigate the current uncertainty regarding the potential immunosuppressive effects of peripheral corticosteroid injections.

Adverse effects of extra-articular corticosteroid injections: a systematic review

It was difficult to accurately quantify the incidence of adverse effects after extra-articular corticosteroid injection, and the reported adverse events were relatively mild, although one fatal reaction was reported.



Intra-articular corticosteroids. An updated assessment.

Clinical experience suggests that intra-articular steroids often ameliorate acute exacerbations of knee osteoarthritis associated with significant effusions, symptomatic involvement of interphalangeal and other nonweight-bearing articulations, synovial cysts, and lumbar facet arthropathy.

Intra-articular corticosteroids. Guide to selection and indications for use.

A literature review suggests that judicious use of intra- and periarticular corticosteroids is very helpful in temporarily reducing pain and inflammation in musculoskeletal structures and may facilitate increased motion and function in selected cases.

Joint and soft-tissue injection. A useful adjuvant to systemic and local treatment.

With attention to the usual cautions required with corticosteroid use and avoidance of contraindications, injection is usually safe and effective, particularly as a bridging technique to long-term therapy.

Intra-articular steroid injections for painful knees. Systematic review with meta-analysis.

Intra-articular corticosteroid injection results in clinically and statistically significant reduction in osteoarthritic knee pain 1 week after injection, and could last for 3 to 4 weeks, but is unlikely to continue beyond that.

Corticosteroid injections for shoulder pain.

A randomized controlled study of post-injection rest following intra-articular steroid therapy for knee synovitis.

It is possible that 24-h post-injection rest will result in a prolonged duration of clinical response and reduce the need for frequent steroid injections and the risk of complications.


It is possible that 24-h post-injection rest will result in a prolonged duration of clinical response and reduce the need for frequent steroid injections and the risk of complications.

Intra-articular corticosteroid preparations: different characteristics and their effect during inflammation induced by monosodium urate crystals in the rat subcutaneous air pouch.

When used for MSU crystal-induced inflammation these corticosteroid preparations suppressed some aspects of inflammation but may actually promote the persistence of MSU crystals and the formation of tophi.

Intraarticular corticosteroid injections: should we rest the joints?

It is suggested that rest is not essential for intraarticular corticosteroids to be beneficial, at least in an inpatient setting, and the applicability of the data to an outpatient population remains to be determined.